2D-DIGE proteomic analysis of changes in estrogen/progesterone-induced rat breast hyperplasia upon treatment with the mongolian remedy RuXian-I

Molecules

Volumn 16, Issue 4, 2011, Pages 3048-3065

  Wang, Zhong Chao ^a   E, Du ^b   Batu, De Ligen ^b   Saixi, Ya Latu ^b   Zhang, Bin ^b   Ren, Li Qun ^a  

^a JILIN UNIVERSITY   (China)

^b INNER MONGOLIA UNIVERSITY FOR NATIONALITIES   (China)

Author keywords

2D DIGE; Breast hyperplasia; Estrogen; Mongolian medicine; Proteomics; Rat

Indexed keywords

ESTROGEN; HERBACEOUS AGENT; PROGESTERONE; RUXIAN I;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; HYPERPLASIA; MASS SPECTROMETRY; METHODOLOGY; PATHOLOGY; PROTEOMICS; RAT; TWO DIMENSIONAL GEL ELECTROPHORESIS; UDDER;

ANIMALS; DRUGS, CHINESE HERBAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ESTROGENS; FEMALE; HYPERPLASIA; MAMMARY GLANDS, ANIMAL; PROGESTERONE; PROTEOMICS; RATS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 79955533423     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16043048     Document Type: Article

References (37)

1. Semiglazov, V.F.; Maksimov, S.I.; Bulgatova, E.A.; Meshkova, I.E.; Chepik, O.F.; Berstein, L.M. Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen. Vopr. Onkol. 2003, 49, 198-204. (Pubitemid 39164071)
2. Von Eggeling, F.; Gawriljuk, A.; Fiedler, W.; Ernst, G.; Claussen, U.; Klose, J.; Römer, I. Fluorescent dual colour 2D-protein gelelectrophoresis for rapid detection of differences in protein pattern with standard image analysis software. Int. J. Mol. Med. 2001, 8, 373-377.
3. Hodgkinson, V.C.; Eagle, G.L.; Drew, P.J.; Lind, M.J.; Cawkwell, L. Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: current status. Cancer. Lett. 2010, 294, 13-24.
4. Braun, M.; Fountoulakis, M.; Papadopoulou, A.; Vougas, K.; Seidel, I.; Höller, T.; Yeghiazaryan, K.; Schild, H.H.; Kuhn, W.; Golubnitschaja, O. Down-regulation of Microfilamental Network-associated Proteins in Leukocytes of Breast Cancer Patients: Potential Application to Predictive Diagnosis. Cancer Genom. Proteom. 2009, 6, 31-40.
5. Umar, A.; Kang, H.; Timmermans, A.M.; Look, M.P.; Meijer-van Gelder, M.E.; den Bakker, M.A.; Jaitly, N.; Martens, J.W.; Luider, T.M.; Foekens, J.A.; Pasa-Tolić, L. Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer. Mol. Cell. Proteom. 2009, 8, 1278-1294.
6. Betancourt, A.M.; Mobley, J.A.; Russo, J.; Lamartiniere, C.A. Proteomic analysis in mammary glands of rat offspring exposed in utero to bisphenol A. J. Proteom. 2010, 73, 1241-1253.
7. Bocchinfuso, W.P.; Lindzey, J.K.; Hewitt, S.C.; Clark, J.A.; Myers, P.H.; Cooper, R.; Korach, K.S. Induction of mammary gland development in estrogen receptor-alpha knockout mice. Endocrinology 2000, 141, 2982-2994. (Pubitemid 32250463)
8. Rohan, T.E.; Negassa, A.; Chlebowski, R.T.; Lasser, N.L.; McTiernan, A.; Schenken, R.S.; Ginsberg, M.; Wassertheil-Smoller, S.; Page, D.L. Estrogen plus progestin and risk of benign proliferative breast disease. Cancer Epidemiol. Biomarkers Prev. 2008, 17, 2337-2343.
9. Crandall, C.J.; Karlamangla, A.; Huang, M.H.; Ursin, G.; Guan, M.; Greendale, G.A. Association of new-onset breast discomfort with an increase in mammographic density during hormone therapy. Arch. Intern. Med. 2006, 166, 1578-1584. (Pubitemid 44232365)
10. Conner, P. Breast response to menopausal hormone therapy-aspects on proliferation, apoptosis and mammographic density. Ann. Med. 2007, 39, 28-41.
11. Ahn, S.H.; Sawada, H.; Ro, J.Y.; Nicolson, G.L. Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues. Clin. Exp. Metastasis 1997, 15, 151-156. (Pubitemid 27157817)
12. Mulla, A.; Christian, H.C.; Solito, E.; Mendoza, N.; Morris, J.F.; Buckingham, J.C. Expression, subcellular localization and phosphorylation status of annexins 1 and 5 in human pituitary adenomas and a growth hormone-secreting carcinoma. Clin. Endocrinol. (Oxf.). 2004, 60, 107-119. (Pubitemid 38183506)
13. Shen, D.; Nooraie, F.; Elshimali, Y.; Lonsberry, V.; He, J.; Bose, S.; Chia, D.; Seligson, D.; Chang, H.R.; Goodglick, L. Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum. Pathol. 2006, 37, 1583-1591. (Pubitemid 44792225)
14. Alldridge, L.C.; Harris, H.J.; Plevin, R.; Hannon, R.; Bryant, C.E. The annexin protein lipocortin 1 regulates the MAPK/ERK pathway. J. Biol. Chem. 1999, 274, 37620-37628. (Pubitemid 30026818)
15. Kushner, P.J.; Agard, D.A.; Greene, G.L.; Scanlan, T.S.; Shiau, A.K.; Uht, R.M.; Webb, P. Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 2000, 74, 311-317. (Pubitemid 32126243)
16. Parmar, H.; Melov, S.; Samper, E.; Ljung, B.M.; Cunha, G.R.; Benz, C.C. Hyperplasia, reduced E-cadherin expression, and developmental arrest in mammary glands oxidatively stressed by loss of mitochondrial superoxide dismutase. Breast 2005, 14, 256-263. (Pubitemid 41110185)
17. Mense, S.M.; Remotti, F.; Bhan, A.; Singh, B.; El-Tamer, M.; Hei, T.K.; Bhat, H.K. Estrogeninduced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure. Toxicol. Appl. Pharmacol. 2008, 232, 78-85.
18. Mobley, J.A.; Brueggemeier, R.W. Brueggemeier estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer. Carcinogenesis 2004, 25, 3-9. (Pubitemid 38128614)
19. Sastre-Serra, J.; Valle, A.; Company, M.M.; Garau, I.; Oliver, J.; Roca, P. Estrogen downregulates uncoupling proteins and increases oxidative stress in breast cancer. Free Radic. Biol. Med. 2010, 48, 506-512.
20. Wójcik, M.; Kosior-Korzecka, U.; Bobowiec, R. Cytoprotective action of 17β-oestradiol against iron-induced hepatic oxidative stress in vitro. Bull Vet. Inst. Pulawy 2010, 54, 259-263.
21. Kim, S.U.; Hwang, C.N.; Sun, H.N.; Jin, M.H.; Han, Y.H.; Lee, H.; Kim, J.M.; Kim, S.K.; Yu, D.Y.; Lee, D.S.; Lee, S.H. Peroxiredoxin I is an indicator of microglia activation and protects againsthydrogen peroxide-mediatedmicroglial death. Biol. Pharm. Bull. 2008, 31, 820-825. (Pubitemid 351731969)
22. Immenschuh, S.; Baumgart-Vogt, E. Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid. Redox Signal. 2005, 7, 768-777. (Pubitemid 40563217)
23. Lee, Y.M.; Park, S.H.; Shin, D.I.; Hwang, J.Y.; Park, B.; Park, Y.J.; Lee, T.H.; Chae, H.Z.; Jin, B.K.; Oh, T.H.; Oh, Y.J. Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease. J. Biol. Chem. 2008, 283, 9986-9998.
24. Mu, Z.M.; Yin, X.Y.; Prochownik, E.V. Pag, a putative tumor suppressor, interacts with the Myc Box II domain of c-Myc and selectively alters its biological function and target gene expression. J. Biol. Chem. 2002, 277, 43175-43184. (Pubitemid 35285703)
25. Daly, K.A.; Lefévre, C.; Nicholas, K.; Deane, E.; Williamson, P. Characterization and expression of Peroxiredoxin 1 in the neonatal tammarwallaby (Macropus eugenii). Comp. Biochem. Physiol B Biochem. Mol. Biol. 2008, 49, 108-119. (Pubitemid 350217039)
26. Hayes, J.D.; Flanagan, J.U.; Jowsey, I.R. Glutathione transferases. Annu. Rev. Pharmacol Toxicol. 2005, 45, 51-88. (Pubitemid 40261798)
27. Meiers, I.; Shanks, J.H. Bostwick DG.Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007. Pathology 2007, 39, 299-304. (Pubitemid 46897603)
28. Lee, J.S. GSTP1 promoter hypermethylation is an early event in breast carcinogenesis. Virchows. Arch. 2007, 450, 637-642. (Pubitemid 46986235)
29. McIlwain, C.C.; Townsend, D.M.; Tew, K.D. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 2006, 25, 1639-1648.
30. Pasquali, L.; Bedeir, A.; Ringquist, S.; Styche, A.; Bhargava, R.; Trucco, G. Quantification of CpG island methylation in progressive breast lesions from normal to invasive carcinoma. Cancer Lett. 2007, 257, 136-144. (Pubitemid 47464705)
31. Parcellier, A.; Schmitt, E.; Brunet, M.; Hammann, A.; Solary, E.; Garrido, C. Small heat shock proteins HSP27 and α B-crystallin: Cytoprotective and oncogenic functions. Antioxid. Redox Signal. 2005, 7, 404-413. (Pubitemid 40279808)
32. Ahmad, M.F.; Raman, B.; Ramakrishna, T.; Rao, Ch.M. Effect of phosphorylation on alpha B - crystallin: differences in stability, subunit exchange and chaperone activity of homo and mixed oligomers of alpha B - crystallin and its phosphorylation -mimicking mutant. J. Mol. Biol. 2008, 375, 1040-1051. (Pubitemid 350309398)
33. Kamradt, M.C.; Chen, F.; Sam, S.; Cryns, V.L. The small heat shock protein alpha B-crystallin negatively regulates apoptosis during myogenic differentiation by inhibiting caspase-3 activation. J. Biol. Chem. 2002, 277, 38731-38736. (Pubitemid 35154735)
34. Sitterding, S.M.; Wiseman, W.R.; Schiller, C.L.; Luan, C.; Chen, F.; Moyano, J.V.; Watkin, W.G.; Wiley, E.L.; Cryns, V.L.; Diaz, L.K. AlphaB-crystallin: a novel marker of invasive basal-like and metaplastic breast carcinomas. Ann. Diagn. Pathol. 2008, 12, 33-40.
35. Moyano, J.V.; Evans, J.R.; Chen, F.; Lu, M.; Werner, M.E.; Yehiely, F.; Diaz, L.K.; Turbin, D.; Karaca, G.; Wiley, E.; et al. AlphaB- crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer. J. Clin. Invest. 2006, 116, 261-270. (Pubitemid 43121811)
36. Launay, N.; Goudeau, B.; Kato, K.; Vicart, P.; Lilienbaum, A. Cell signaling pathways to alpha B-crystallin following stresses of the cytoskeleton. Exp. Cell. Res. 2006, 312, 3570-3584. (Pubitemid 44470775)
37. Polavarapu, R.; Spitz, D.R.; Sim, J.E.; Follansbee, M.H.; Oberley, L.W.; Rahemtulla, A.; Nanji, A.A. Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil. Hepatology 1998, 27, 1317-1323. (Pubitemid 28227859)